CORUS Clinical Nutrition

ResearchReading list
Prelaunch materials · November 2026

Reading list: muscle, protein and nutrition in older age

The published research behind CORUS: the condition, protein needs, how older muscle responds to protein, the evidence on each core ingredient, and the approaches clinicians already use. It is background reading, not evidence that CORUS works.

Download the reading list as a PDF11 pages, 107 KB, US Letter

About this reading list

These studies examine ingredients, related formulas and clinical nutrition; they did not test CORUS. Each entry says who took part and what was measured. Summaries are ours, written from each paper’s abstract or text; please read the original before relying on it.

Sarcopenia

Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2)Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Age Ageing. 2019;48(1):16-31. doi:10.1093/ageing/afy169

Type
Consensus definition from a European expert working group.
What it says
Sarcopenia is a muscle disease. Low muscle strength is the key characteristic, low muscle quantity or quality confirms the diagnosis, and poor physical performance marks it as severe. It is common in older adults but can occur earlier in life. The paper sets out a pathway for case-finding, diagnosis and severity, with cut-off points.
Study context
Defines and diagnoses the condition.

Global prevalence of sarcopenia and severe sarcopeniaPetermann-Rocha F, Balntzi V, Gray SR, et al. J Cachexia Sarcopenia Muscle. 2022;13(1):86-99. doi:10.1002/jcsm.12783

Type
Systematic review and meta-analysis: 263 studies reviewed, 151 pooled (692,056 people, mean age 68.5).
What it found
Prevalence ranged from 10% to 27% in people aged 60 and older, and severe sarcopenia from 2% to 9%, depending on the classification and cut-off points used.
Study context
How common the condition is, not how to manage it.

SarcopeniaSayer AA, Cooper R, Arai H, et al. Nat Rev Dis Primers. 2024;10(1):68. doi:10.1038/s41572-024-00550-w

Type
Narrative review (primer).
What it says
Sarcopenia can lead to declining physical function and mobility and raises the risk of falls, fractures and premature mortality. Diagnosis increasingly centers on muscle strength. Resistance exercise is the mainstay of treatment but is not suitable for everyone, so other approaches are needed.
Study context
An overview of the condition.

Clinical guidance

ESPEN practical guideline: clinical nutrition and hydration in geriatricsVolkert D, Beck AM, Cederholm T, et al. Clin Nutr. 2022;41(4):958-989. doi:10.1016/j.clnu.2022.01.024

Type
Clinical practice guideline: 82 recommendations, graded for evidence and consensus.
Who
Older persons in all care settings.
What it says
Screen all older persons for malnutrition routinely, with a validated tool (recommendation 12). Protein intake should be at least 1 g/kg body weight per day, adjusted to the person (2). For people with or at risk of malnutrition: individualized counseling, fortified food, snacks, and supplement drinks when those are not enough (21 to 26), adapted to each person’s taste and eating capacities (31).
Study context
General practice guidance.

Evidence-based recommendations for optimal dietary protein intake in older people (PROT-AGE)Bauer J, Biolo G, Cederholm T, et al. J Am Med Dir Assoc. 2013;14(8):542-559. doi:10.1016/j.jamda.2013.05.021

Type
Position paper from an international expert group.
Who
Adults older than 65.
What it says
Older adults need more dietary protein than younger adults. Average intake of at least 1.0 to 1.2 g protein/kg/day; 1.2 g/kg/day or more for people who exercise or are otherwise active; 1.2 to 1.5 g/kg/day for most with acute or chronic disease. People with severe kidney disease (eGFR below 30) who are not on dialysis may need to limit protein. Evidence on protein quality and timing is not yet sufficient for specific recommendations.
Study context
Intake targets, not evidence that any product helps people meet them.

Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert GroupDeutz NE, Bauer JM, Barazzoni R, et al. Clin Nutr. 2014;33(6):929-936. doi:10.1016/j.clnu.2014.04.007

Type
Expert group recommendations.
Who
Older people, healthy and ill.
What it says
At least 1.0 to 1.2 g protein/kg/day for healthy older people; 1.2 to 1.5 g/kg/day for those malnourished or at risk because of acute or chronic illness; daily physical activity or exercise for all older people for as long as possible. Protein combined with exercise is considered optimal for maintaining muscle function.
Study context
General recommendations.

GLIM criteria for the diagnosis of malnutritionCederholm T, Jensen GL, Correia MITD, et al. Clin Nutr. 2019;38(1):1-9. doi:10.1016/j.clnu.2018.08.002

Type
Global consensus report.
Who
Adults in clinical settings.
What it says
Diagnosis has two steps: screening with any validated tool, then assessment. It needs at least one phenotypic criterion (unintended weight loss, low body mass index, reduced muscle mass) and one etiologic criterion (reduced food intake or assimilation, inflammation or disease burden).
Study context
How malnutrition is diagnosed.

How much protein older adults eat

Prevalence of protein intake below recommended in community-dwelling older adultsHengeveld LM, Boer JMA, Gaudreau P, et al. J Cachexia Sarcopenia Muscle. 2020;11(5):1212-1222. doi:10.1002/jcsm.12580

Type
Population study: meta-analysis of four cohorts and four national surveys (PROMISS project).
Who
8,107 community-dwelling adults aged 55 and older in the Netherlands, the UK, Canada, the USA, Finland and Italy.
What it found
Pooled prevalence of protein intake below 0.8, 1.0 and 1.2 g/kg adjusted body weight per day: 21.5%, 46.7% and 70.8%. Prevalence was higher among women, people with higher body mass index and people with poor appetite.
Study context
It measures the size of a gap, not how to close it.

How older muscle responds to protein

Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscleCuthbertson D, Smith K, Babraj J, et al. FASEB J. 2005;19(3):422-424. doi:10.1096/fj.04-2640fje

Type
Laboratory study.
Who
44 healthy young and older men of similar build, given different amounts of essential amino acids.
What it found
Resting muscle protein synthesis did not differ, but the older men showed less sensitivity and responsiveness to essential amino acids, with lower activation of signaling proteins such as mTOR.
Study context
A mechanism in healthy men.

Splanchnic and whole-body leucine kinetics in young and elderly menBoirie Y, Gachon P, Beaufrère B. Am J Clin Nutr. 1997;65(2):489-495. doi:10.1093/ajcn/65.2.489

Type
Laboratory study.
Who
6 young (mean age 22.7) and 6 older (68.2) men, during a standard meal.
What it found
The gut and liver took up about twice as much dietary leucine in the older men (50 ± 11% against 23 ± 2%), which could lower the leucine reaching the rest of the body.
Study context
Twelve men, one meal.

A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderlyKatsanos CS, Kobayashi H, Sheffield-Moore M, et al. Am J Physiol Endocrinol Metab. 2006;291(2):E381-E387. doi:10.1152/ajpendo.00488.2005

Type
Laboratory study.
Who
Two older and two young groups, each given 6.7 g of essential amino acids.
What it found
In the older adults, muscle protein synthesis rose only when the mix had a higher share of leucine (41%, against 26% in a mix patterned on whey protein). In the young adults it rose with both.
Study context
Free amino acid mixes in a laboratory, not food.

Protein ingestion to stimulate myofibrillar protein synthesis requires greater relative protein intakes in healthy older versus younger menMoore DR, Churchward-Venne TA, Witard O, et al. J Gerontol A Biol Sci Med Sci. 2015;70(1):57-62. doi:10.1093/gerona/glu103

Type
Laboratory data, pooled and analyzed retrospectively.
Who
Healthy older (about 71) and younger (about 22) men, given 0 to 40 g of protein.
What it found
Muscle protein synthesis reached a plateau at 0.40 ± 0.19 against 0.24 ± 0.06 g/kg body mass (p = .055), and 0.60 ± 0.29 against 0.25 ± 0.13 g/kg lean body mass (p < .01), in older against younger men. Older men were less sensitive to low protein intakes.
Study context
Single meals in healthy men.

The effect of leucine-enriched beta-lactoglobulin versus an isonitrogenous whey protein isolate on skeletal muscle protein anabolism in young healthy malesEly IA, Paul M, Wall JJS, et al. Nutrients. 2025;17(21):3410. doi:10.3390/nu17213410

Type
Laboratory study, crossover. General science only.
Who
10 healthy young men (26 ± 2 years).
What it found
About 10 g of beta-lactoglobulin, a naturally leucine-rich protein found in whey, raised blood essential amino acids and leucine more than the same amount of whey protein isolate. Muscle protein synthesis rose similarly with both, at rest and after exercise.
Study context
Young men, not older adults. It shows that more leucine in the blood does not by itself mean more muscle building.

Trials of related formulas

Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults (PROVIDE)Bauer JM, Verlaan S, Bautmans I, et al. J Am Med Dir Assoc. 2015;16(9):740-747. doi:10.1016/j.jamda.2015.05.021

Type
Trial: related formula. Randomized, double-blind, isocaloric control, 13 weeks.
Who
380 older adults with sarcopenia (SPPB 4 to 9, low muscle mass), mostly living independently.
What it found
Handgrip strength and SPPB, the primary outcomes, improved in both groups with no difference between them. Chair-stand time was 1.01 s faster and appendicular muscle mass 0.17 kg higher with the formula.
Study context
A different formula, with added leucine.

Improving rehabilitation in sarcopenia: a randomized-controlled trial utilizing a muscle-targeted food for special medical purposesRondanelli M, Cereda E, Klersy C, et al. J Cachexia Sarcopenia Muscle. 2020;11(6):1535-1547. doi:10.1002/jcsm.12532

Type
Trial: related formula. Randomized, double-blind, isocaloric control, 4 to 8 weeks.
Who
140 adults with sarcopenia (age 81 ± 6) in hospital physical rehabilitation.
What it found
Gait speed rose 0.063 m/s per month more than with the control formula. Muscle mass and the key secondary outcomes also favored the formula. 13 people, across both groups, stopped because they disliked the product.
Study context
A different formula with added leucine, given alongside rehabilitation exercise.

Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life and decreases inflammation in sarcopenic elderlyRondanelli M, Klersy C, Terracol G, et al. Am J Clin Nutr. 2016;103(3):830-840. doi:10.3945/ajcn.115.113357

Type
Trial: related formula. Randomized, double-blind, placebo-controlled, 12 weeks.
Who
130 adults with sarcopenia (mean age 80.3), all in a controlled physical activity program.
What it found
Fat-free mass was 1.7 kg higher than with placebo. Handgrip strength and activities of daily living also favored the supplement.
Study context
A different formula with added amino acids, including leucine, given with exercise.

Effects of whey protein, leucine, and vitamin D supplementation in patients with sarcopeniaChang MC, Choo YJ. Nutrients. 2023;15(3):521. doi:10.3390/nu15030521

Type
Review of trials: systematic review and meta-analysis of 3 trials (637 patients).
What it found
Appendicular muscle mass improved with or without exercise. Grip strength and SPPB improved only when exercise was added.
Study context
Three trials of formulas with added leucine.

HMB

Effect of beta-hydroxy-beta-methylbutyrate (HMB) on lean body mass during 10 days of bed rest in older adultsDeutz NE, Pereira SL, Hays NP, et al. Clin Nutr. 2013;32(5):704-712. doi:10.1016/j.clnu.2013.02.011

Type
Trial: HMB. Randomized, double-blind, inactive placebo.
Who
24 healthy adults aged 60 to 76 (20 women), 19 evaluable, on 10 days of complete bed rest.
What it found
The control group lost 2.05 kg of lean body mass; the HMB group lost 0.17 kg, with one participant excluded. Function did not differ. The authors call for a larger trial.
Study context
HMB on its own, in a small group of healthy volunteers.

Effects of beta-hydroxy-beta-methylbutyrate supplementation on older adults with sarcopeniaYang C, Song Y, Li T, et al. J Nutr Health Aging. 2023;27(5):329-339. doi:10.1007/s12603-023-1911-1

Type
Trial: HMB, with exercise. Randomized, double-blind, placebo-controlled, 12 weeks.
Who
34 adults aged 60 and older with sarcopenia; both groups did resistance training twice a week.
What it found
Handgrip strength, gait speed and chair-stand time were better than with placebo. Skeletal muscle mass did not differ.
Study context
HMB on its own, added to resistance training, in a small group.

Long-term effects of calcium beta-hydroxy-beta-methylbutyrate and vitamin D3 supplementation on muscular function in older adults with and without resistance trainingRathmacher JA, Pitchford LM, Khoo P, et al. J Gerontol A Biol Sci Med Sci. 2020;75(11):2089-2097. doi:10.1093/gerona/glaa218

Type
Trial: HMB with vitamin D. Randomized, double-blind, controlled, 12 months, with or without resistance training.
Who
238 adults over 60 with insufficient vitamin D enrolled; 117 completed the 12-month trial and were included in the per-protocol analysis.
What it found
Among those not exercising, lean mass at 6 months, knee extension torque at 3 months and a composite function index at 3, 6 and 12 months were better than with control. Among those exercising, it added no further function benefit.
Study context
HMB and vitamin D without protein, in people with low vitamin D.

Effects of oral supplementation of beta-hydroxy-beta-methylbutyrate on muscle mass and strength in individuals over the age of 50Li N, Chen S, He Y, et al. Front Nutr. 2025;12:1522287. doi:10.3389/fnut.2025.1522287

Type
Review of trials: meta-analysis of 21 trials (1,935 participants over 50).
What it found
Lean mass 0.28 kg higher (95% CI 0.16 to 0.41), with small differences in handgrip strength, chair-stand time and gait speed.
Study context
Many HMB products and populations, pooled.

An umbrella review of systematic reviews of beta-hydroxy-beta-methyl butyrate supplementation in ageing and clinical practicePhillips SM, Lau KJ, D’Souza AC, Nunes EA. J Cachexia Sarcopenia Muscle. 2022;13(5):2265-2275. doi:10.1002/jcsm.13030

Type
Review of reviews: 15 systematic reviews.
What it found
5 of 15 reviews found some evidence for lean soft-tissue mass and 4 of 12 for strength. None reported a positive effect on physical function. The authors describe “minor, inconsistent support” for HMB.
Study context
HMB in general, across many products and populations.

Vitamin D

The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle powerBeaudart C, Buckinx F, Rabenda V, et al. J Clin Endocrinol Metab. 2014;99(11):4336-4345. PubMed 25033068

Type
Systematic review and meta-analysis of 30 randomized trials.
Who
Varied populations (5,615 participants), not limited to older adults.
What it found
Vitamin D supplementation had a small positive effect on muscle strength. The effect on muscle mass was not significant.
Study context
Vitamin D as a single nutrient, pooled across mixed populations and doses.

Effect of vitamin D monotherapy on indices of sarcopenia in community-dwelling older adultsProkopidis K, Giannos P, Katsikas Triantafyllidis K, et al. J Cachexia Sarcopenia Muscle. 2022;13(3):1642-1652. doi:10.1002/jcsm.12976

Type
Systematic review and meta-analysis of 10 randomized trials of vitamin D alone.
Who
Community-dwelling older adults.
What it found
Vitamin D on its own gave no improvement in muscle strength, muscle mass or physical performance.
Study context
Vitamin D monotherapy, not a combination formula. It helps interpret the vitamin D in the related formulas above.

Appetite in older age

Anorexia of aging: risk factors, consequences, and potential treatmentsLandi F, Calvani R, Tosato M, et al. Nutrients. 2016;8(2):69. doi:10.3390/nu8020069

Type
Narrative review.
What it describes
Anorexia of aging, a decline in appetite or food intake in old age, is common and contributes to undernutrition. It is not an unavoidable part of aging, and its causes include physiological change, disease, and social and environmental factors.
Study context
Background on why intake falls.

Fortifying everyday food

Effects of dietary enrichment with conventional foods on energy and protein intake in older adultsTrabal J, Farran-Codina A. Nutr Rev. 2015;73(9):624-633. doi:10.1093/nutrit/nuv023

Type
Systematic review of nine studies.
What it tested
Enriching meals with conventional foods or powdered modules to raise energy and protein density without much more volume.
What it found
Enrichment can improve energy intake. It seems to increase protein intake, but the evidence was not of sufficient quality to confirm that, or to judge other outcomes.
Study context
Other foods and modules. The evidence on protein was limited even for those.

Can fortified foods and snacks increase the energy and protein intake of hospitalised older patients?Mills SR, Wilcox CR, Ibrahim K, Roberts HC. J Hum Nutr Diet. 2018;31(3):379-389. doi:10.1111/jhn.12529

Type
Systematic review of ten articles (546 patients).
Who
Hospital and rehabilitation patients with a mean age of 60 to 83.
What it found
Compared with usual care, six studies of energy- or protein-based fortification or snacks significantly increased energy (250 to 450 kcal/day) or protein (12 to 16 g/day) intake. Four studies reported good acceptability.
Study context
Hospital settings and other products.

Impact of food-based fortification on nutritional outcomes and acceptability in older adultsGeny A, Petitjean M, Van Wymelbeke-Delannoy V, Sulmont-Rossé C. Front Nutr. 2023;10:1232502. doi:10.3389/fnut.2023.1232502

Type
Systematic review of 44 studies (3,384 participants).
Who
Adults aged 60 and older, at home, in institutions or in hospital.
What it found
Compared with a standard diet, adding fortificants to everyday recipes seems to be a valuable way to raise energy and protein intake, but there was no strong evidence of an effect on nutritional status. The authors call for more acceptability research.
Study context
Other recipes and fortificants.

Older adults’ acceptability of and preferences for food-based protein fortification in the UK, France and NorwaySmith R, Methven L, Clegg ME, et al. Appetite. 2024;197:107319. doi:10.1016/j.appet.2024.107319

Type
Discussion groups, then a home-use trial (Fortiphy project).
Who
Discussions with 37 older adults and 15 caregivers; a home trial with 158 healthy adults aged 70 and older.
What it found
Participants were largely unaware of the role of protein in aging and did not want to fortify their own food at present, but were positive about the idea. Taste, familiar ingredients and preferred ways of preparing food mattered, and preferences differed by country.
Study context
Other recipes, made by healthy volunteers.

Supplement drinks in practice

A systematic review of compliance to oral nutritional supplementsHubbard GP, Elia M, Holdoway A, Stratton RJ. Clin Nutr. 2012;31(3):293-312. doi:10.1016/j.clnu.2011.11.020

Type
Systematic review of 46 studies (4,328 participants).
What it found
Mean compliance with oral nutritional supplements was 78%: 67% in hospital and 81% in the community. Compliance was higher with more energy-dense supplements.
Note
The first author’s listed affiliation is a supplement manufacturer’s medical affairs department.
Study context
It concerns supplement drinks, not powders added to food.

Screening tools clinicians use

Validation of the Mini Nutritional Assessment short-form (MNA-SF)Kaiser MJ, Bauer JM, Ramsch C, et al. J Nutr Health Aging. 2009;13(9):782-788. doi:10.1007/s12603-009-0214-7

Type
Validation study pooling twelve datasets.
Who
2,032 older participants with a mean age of 82.3.
What it found
The revised short form, which can use calf circumference when body mass index is unavailable, is a valid nutrition screening tool for geriatric health professionals.
Study context
A clinician’s screening tool, not a product assessment.

Citations checked against PubMed and Crossref on 2 November 2026.